These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8938474)

  • 1. Use of a second-generation CA125 assay in gynecologic patients.
    Hornstein MD; Goodman HM; Thomas PP; Knapp RC; Harlow BL
    Gynecol Obstet Invest; 1996; 42(3):196-200. PubMed ID: 8938474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OVCA (CA125) second generation: technical aspects and serum levels in controls, patients with liver disease, pregnant women and patients with ovarian disease.
    Cioffi M; Fratta M; Gazzerro P; Di Finizio B; Tucci A; Molinari AM
    Tumori; 1997; 83(2):594-8. PubMed ID: 9226027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the cyclic variation in serum levels of CA125 across the menstrual cycle using two commercial assays.
    McLemore MR; Aouizerat BE; Lee KA; Chen LM; Cooper B; Tozzi M; Miaskowski C
    Biol Res Nurs; 2012 Jul; 14(3):250-6. PubMed ID: 21765119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of second generation CA 125 assays.
    Cosmi EV; Atlante G; Donadio C; Mariani L; Barbati A
    Eur J Obstet Gynecol Reprod Biol; 1995 Jan; 58(1):73-6. PubMed ID: 7758648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference value.
    Bonfrer JM; Korse CM; Verstraeten RA; van Kamp GJ; Hart GA; Kenemans P
    Clin Chem; 1997 Mar; 43(3):491-7. PubMed ID: 9068593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of HE4 and CA125 levels in women with benign gynecologic disorders : Does age or menopausal status matter?
    Delić R; Štefanović M; Krivec Š; Weber V; Koren J
    Wien Klin Wochenschr; 2016 Dec; 128(Suppl 7):543-547. PubMed ID: 27752776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of factors that may be responsible for cyclic change of CA125 levels during menstrual cycle.
    Kafali H; Artunc H; Erdem M
    Arch Gynecol Obstet; 2007 Mar; 275(3):175-7. PubMed ID: 16983562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases.
    Park Y; Lee JH; Hong DJ; Lee EY; Kim HS
    Clin Biochem; 2011 Jul; 44(10-11):884-8. PubMed ID: 21549107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of a new serum tumor marker, CA125II, in gynecologic disease: comparison with CA125.
    Tamakoshi K; Kikkawa F; Hasegawa N; Ishikawa H; Mizuno K; Kawai M; Tomoda Y
    Gynecol Obstet Invest; 1995; 39(2):125-9. PubMed ID: 7737582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay.
    Bristow RE; Smith A; Zhang Z; Chan DW; Crutcher G; Fung ET; Munroe DG
    Gynecol Oncol; 2013 Feb; 128(2):252-9. PubMed ID: 23178277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report.
    Kafali H; Artuc H; Demir N
    Eur J Obstet Gynecol Reprod Biol; 2004 Sep; 116(1):85-8. PubMed ID: 15294374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predictive of elevated serum CA125 levels in patients with epithelial ovarian cancer.
    Bouanène H; Harrabi I; Ferchichi S; Ben Limem H; Miled A
    Bull Cancer; 2007 Jul; 94(7):E18-22. PubMed ID: 17723943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The sensitivity of the CA125 immunoradiometric assay for patients with epithelial ovarian cancer and its correlation with complex treatment].
    Shi W; Zhang YJ; Jiang CY
    Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):604-6, 637-8. PubMed ID: 7712875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters.
    Kouris NT; Zacharos ID; Kontogianni DD; Goranitou GS; Sifaki MD; Grassos HE; Kalkandi EM; Babalis DK
    Eur J Heart Fail; 2005 Mar; 7(2):199-203. PubMed ID: 15701467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined detection of sialic acid and hydroxyproline in diagnosis of ovarian cancer and its comparison with human epididymis protein 4 and carbohydrate antigen 125.
    Li PL; Zhang X; Li TF; Wang LL; Du LT; Yang YM; Li J; Wang HY; Zhang Y; Wang CX
    Clin Chim Acta; 2015 Jan; 439():148-53. PubMed ID: 25445414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and technical evaluation of the ACS:OV serum assay and comparison with three other CA125-detecting assays.
    Davelaar EM; Schutter EM; von Mensdorff-Pouilly S; van Kamp GJ; Verstraeten RA; Kenemans P
    Ann Clin Biochem; 2003 Nov; 40(Pt 6):663-73. PubMed ID: 14629806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of serum CA125 assays in the diagnosis of uterine adenomyosis].
    Zhou Y; Wu B; Li H
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):590-3. PubMed ID: 9275451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of urine cystein proteinase and serum CA125 measurement in monitoring the treatment of malignant ovarian tumor].
    Gao G; Peng Z; He B
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):291-4. PubMed ID: 9389065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.